QANDLI DIABETNING 2-BOSQICHIDA KARDIOMIOPATIYANI O‘RGANISH

##plugins.themes.bootstrap3.article.sidebar##

PDF (Русский)
Nashr: Jild 5 Nomeri 3 : Евразийский журнал медицинских и естественных наук
Bo'lim: Статьи
##semicolon##
##submission.license.cc.by4.footer##

##plugins.themes.bootstrap3.article.main##

Младших научный сотрудник, Институт биофизики и биохимии при Национальном университете Узбекистана.
nad1ra.idrsv@icloud.com
Магистрант, Национальный университет Узбекистана.
nad1ra.idrsv@icloud.com
Доцент кафедры физиологии человека животных, Национальный университет Узбекистана.
nad1ra.idrsv@icloud.com

Abstrak:

Qandli diabetdagi kardiyomiyopatiya (DM) yurak mushaklaridagi strukturaviy va funktsional o'zgarishlar bilan tavsiflangan murakkab kasallikdir. Kasallikning ikkinchi bosqichida progressiv o'zgarishlar, shu jumladan miyokard gipertrofiyasi, fibroz va energiya almashinuvining buzilishi kuzatiladi. Ushbu maqolada diabetning 2-bosqichida kardiyomiyopatiyaning rivojlanish mexanizmlari, giperglikemiya, oksidlovchi stress va yallig'lanish jarayonlarining miyokardga ta'siri, shuningdek, diagnostika va davolashning zamonaviy usullari, shu jumladan dori-darmon va dori-darmonlarga qarshi yondashuvlar muhokama qilinadi.

##semicolon##

##plugins.themes.bootstrap3.article.details##

##submission.howToCite##:

Ходжиев , С. ., Идриисова , Н. ., & Кахоров , Б. . (2025). QANDLI DIABETNING 2-BOSQICHIDA KARDIOMIOPATIYANI O‘RGANISH. Yevrosiyo Tibbiyot Va Tabiiy Fanlar Jurnali, 5(3), 27–32. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/46726

##submission.citations##:

Kannel, W. B., & McGee, D. L. (1979). Diabetes and cardiovascular disease: The Framingham study. JAMA, 241(19), 2035–2038. https://doi.org/10.1001/jama.1979.03300430035028

Fisman, E. Z., & Tenenbaum, A. (2009). The impact of diabetes on cardiovascular disease. Diabetes Care, 32(Suppl 2), S360–S367. https://doi.org/10.2337/dc09-S360

Kannel, W. B., & Vasan, R. S. (2009). Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Archives of Internal Medicine, 169(8), 755–760. https://doi.org/10.1001/archinternmed.2009.72

Boudina, S., & Abel, E. D. (2007). Diabetic cardiomyopathy, causes and effects. Reviews in Endocrine & Metabolic Disorders, 8(1), 31-39. https://doi.org/10.1007/s11154-007-9040-5

American Diabetes Association. (2020). 11. Cardiovascular disease and risk management: Standards of medical care in diabetes—2020. Diabetes Care, 43(Supplement 1), S111–S134. https://doi.org/10.2337/dc20-S011

Aguero, J., & Tarazón, E. (2013). Cardiac involvement in diabetes: Clinical implications of the diabetic cardiomyopathy. Endocrine Research, 38(4), 155-169. https://doi.org/10.3109/07435800.2013.773435

Manczak, M., & Muntner, P. (2018). Diabetes and heart failure: A review. American Journal of Cardiovascular Disease, 8(3), 67-76.

Packer, M., & Myerson, M. (2014). Diabetic cardiomyopathy: Pathophysiology and clinical implications. Heart Failure Clinics, 10(4), 477-485. https://doi.org/10.1016/j.hfc.2014.07.005.

Yarkinboeva, M. R., & Kahorov, B. A. (2024). SPECIFIC CHARACTERISTICS OF THE DETERMINATION OF BIOLOGICAL TRACES OF CRIME. Spectrum Journal of Innovation, Reforms and Development, 28, 32-33.

Kakhorov, B. A., Rasulova, S. L., Zhumakulova, G. S., & Shavkatova, H. R. (2024). COMPLEX EVALUATION OF BIOSTIMULANTS FOR PREVENTION OF IMMUNE SYSTEM DISORDERS AND HIGHLY PRODUCTIVE COWS AND IMPROVEMENT OF MILK QUALITY. American Journal Of Biomedical Science & Pharmaceutical Innovation, 4(01), 39-45.

Kahorov, B. A., & Rasulova, S. L. (2023). INFLUENCE OF MODIFIED PEPTIDES FROM THE FETAL THYMUS ON THE ACTIVITY OF T-LYMPHOCYTES AND NATURAL KILLERS IN EXPERIMENTAL VIRAL HEPATITIS. American Journal Of Biomedical Science & Pharmaceutical Innovation, 3(12), 48-55.

GARIB, F. Y., KAKHOROV, B. A., KHUZHAMKULOVA, M. Z., & KUCHBOEV, A. E. (2021). Effect of modified peptides from fetal thymus on the activity of T-lymphocytes and natural killers and interferonindual activity of sanogen and betaleukin. International Journal of Pharmaceutical Research (09752366), 13(3).

Kayumov, K., Kuchkarova, L., & Kakhorov, B. (2021). Etiology of Pancreatitis and Rutin Treatment of the Disease. Annals of the Romanian Society for Cell Biology, 585-589.

Adilbekov, T. T., & Kakharov, B. A. (2021). PHARMACOLOGY SUPPLY OF THE PROCESS OF PHYSICAL PREPARATION OF ATHLETES. Academic research in educational sciences, 2(2), 1128-1133.

ZAYNITDINOVA, D., & KHYZHAMKULOVA, M. Bolta KAKHOROV. MUTATIONAL VARIABILITY OF BARLEY IN DIFFERENT ALTITUDE ZONES. (in Russian)

Kakhorov, B. A., Rasulova, S. L., Khaitova, F. B., Tukhtaeva, E. I., & Kataeva, Yu. A. (2023). Effect of peptide biostimulants on the immune system in experimental hepatitis. (in Russian)

KAKHOROV, B. (2024). EFFECT OF MODIFIED PEPTIDES FROM FETAL THYMUS ON THE ACTIVITY OF T-LYMPHOCYTES AND NATURAL KILLERS.World of Scientific news in Science, 2(6), 382-397. (in Russian)